The recent study indicates that weight-loss medications like Wegovy and Zepbound may significantly reduce the risk of opioid overdose and alcohol intoxication among users with substance-use disorders.
Research suggests that the weight-loss drugs target hormones that impact various aspects of health, including appetite, heart health, and brain reward circuits, beyond just weight management.
The data analyzed showed that patients with opioid-use disorders taking these medications experienced a 40% reduction in overdose incidents, while those with alcohol-use disorders had a 50% decrease in intoxication.
These findings imply that the positive effects of drugs targeting GLP-1 and GIP hormones could provide critical support for individuals battling addiction, enhancing their overall treatment outcomes.
#weight-loss-medications #substance-use-disorders #opioid-overdose #alcohol-intoxication #health-benefits
Collection
[
|
...
]